C3 Cannabinoid Company

Canadian cannabis giant Canopy Growth Corp (NYSE: CGC) announced a new global brand that will include all of the company's medical operations. What Happened Canopy's new brand, Spectrum Therapeutics, will incorporate the company's ongoing commercial medical and clinical research...

Canopy Growth Corp (NYSE: CGC) is strengthening its presence in Germany and Europe with the acquisition of C3 Cannabinoid Compound Company, a leading manufacturer and distributor of dronabinol, a synthetic cannabinoid. What Happened The value of the transaction is 225.9 million euro (about $254...